Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
Saved in:
| Title: | Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study. |
|---|---|
| Authors: | Combe, Bernard G.1,2 (AUTHOR) b-combe@chu-montpellier.fr, Tanaka, Yoshiya3 (AUTHOR), Buch, Maya H.4 (AUTHOR), Nash, Peter5 (AUTHOR), Burmester, Gerd R.6 (AUTHOR), Kivitz, Alan J.7 (AUTHOR), Bartok, Beatrix8 (AUTHOR), Pechonkina, Alena8 (AUTHOR), Xia, Katrina8 (AUTHOR), Emoto, Kahaku9 (AUTHOR), Kano, Shungo9 (AUTHOR), Hendrikx, Thijs K.10 (AUTHOR), Landewé, Robert B. M.11 (AUTHOR), Aletaha, Daniel12 (AUTHOR) |
| Source: | Rheumatology & Therapy. Feb2023, Vol. 10 Issue 1, p71-72. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21986576 |
|---|---|
| DOI: | 10.1007/s40744-022-00530-0 |
